What is Physera?
Physera operates at the intersection of clinical physical therapy and scalable health technology. The company provides a virtual care program designed to deliver personalized treatment plans for individuals suffering from musculoskeletal issues. By leveraging a nationwide network of licensed therapists and proprietary digital tools, Physera facilitates remote care that is both accessible and clinically rigorous. Its integration into the Omada Health ecosystem allows for a more holistic approach to chronic condition management, emphasizing long-term member outcomes and significant cost savings for enterprise partners. The platform is engineered to drive meaningful change in patient health, with data-backed results demonstrating high member satisfaction and reduced reliance on invasive procedures.
How much funding has Physera raised?
Physera has raised a total of $10.8M across 2 funding rounds:
Private Equity
$2.8M
Series A
$8M
Private Equity (2017): $2.8M with participation from Slow Ventures, Innovation Endeavors, Expa, and Lux Capital
Series A (2019): $8M, investors not publicly disclosed
Key Investors in Physera
Innovation Endeavors
Innovation Endeavors is an early-stage venture capital firm that invests in visionary founders, transformational technologies and emergent ecosystems, focusing on the intersection of data and advanced engineering.
Expa
Expa is a startup studio and investment firm founded by Uber co-founder Garrett Camp, dedicated to providing entrepreneurs with the capital, network, and operational expertise required to launch and scale new companies.
Lux Capital
Lux Capital is a venture capital firm that invests in early-stage and growth-stage companies at the intersection of science and technology, with a focus on frontier areas such as biotechnology and AI.
What's next for Physera?
With the support of its strategic investors, Physera is well-positioned to scale its virtual care pathways across diverse enterprise environments. The focus moving forward will likely center on deepening the integration of its MSK program within the broader Omada Health suite, enhancing the predictive capabilities of its care algorithms, and expanding its network of licensed providers to meet growing demand. As the digital health sector matures, Physera's ability to prove clinical efficacy and cost-efficiency will be paramount in securing its status as a standard-bearer for virtual musculoskeletal health. The company is expected to leverage its recent capital to refine its user experience and broaden its market penetration, ultimately aiming to redefine the standard of care for chronic MSK management on a national scale.
See full Physera company page
